SEQUOIA SCIENCES
Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers. Their development programs consist of small molecules targeting bacterial infections and cancers, and also vaccines for the treatment and prevention of recurrent urinary tract infections. Their goal is to improve the quality of life for those individuals significantly affected by recurrent and chronic bacterial infections and cancers. Sequoia is engaged ... in research and development programs and collaborations with laboratories, universities, clinical research sites, and private businesses. They have applied their microscale structure determination expertise to elucidate structures of natural products, biosynthetic intermediates, and unexpected synthetic products for academic and industrial collaborators.
SEQUOIA SCIENCES
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
1999-01-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.sequoiasciences.com
Total Employee:
11+
Status:
Active
Contact:
+1 314 373 5181
Email Addresses:
[email protected]
Total Funding:
72 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Squarespace Hosted Microsoft DNS
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Employees Featured
Founder
Investors List
St. Louis Arch Angels
St. Louis Arch Angels investment in Seed Round - Sequoia Sciences
Cultivation Capital
Cultivation Capital investment in Seed Round - Sequoia Sciences
Official Site Inspections
http://www.sequoiasciences.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Sequoia Sciences" on Search Engine
Sequoia Sciences Receives FDA Fast Track Designation for …
LOUIS, July 26, 2017 /PRNewswire/ -- Sequoia Sciences announced it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its novel, …See details»
Sequoia Sciences Company Profile - Craft
Sequoia Sciences is a pharmaceutical company developing medicines targeting bacterial infections and cancers. Its pipeline includes a vaccine for the treatment and prevention of …See details»
Sequoia Sciences, Inc. Receives FDA Fast Track Designation
Jul 26, 2017 Sequoia Sciences is a pharmaceutical company discovering and developing new medicines targeting bacterial infections and cancers. Our pipeline includes a …See details»
Sequoia Sciences Backed by Prolog Ventures, Holton Capital
Dec 31, 2012 Prolog Ventures and Holton Capital have anted up $1.5 million in later-stage venture funds for Sequoia Sciences, a drug developer based in St. Louis, MO. …See details»
Sequoia Vaccines Begins $20 Million IPO Effort - Seeking Alpha
Nov 7, 2023 Sequoia Vaccines, Inc. ( SQVI) has filed to raise $20 million in an IPO of its common stock, according to an SEC S-1 registration statement. The firm is a clinical …See details»
Michael Holmes - Director at Sequoia Sciences | The Org
Sequoia Sciences. Michael Holmes. MH. Michael Holmes. Director at Sequoia Sciences. Show contact. Michael Holmes is the Chairman Emeritus and Founder of Rx Outreach, …See details»
Careers - Sequoia Website
With a people-centric focus, Sequoia has a proven track record of attracting and retaining top talent— this includes a substantial and growing team of tenured professionals who …See details»
Sequoia Sciences - Overview, News & Similar companies
(314) 373-5181. site. www.sequoiasciences.com. Revenue. <$5 Million. Industry. Pharmaceuticals Healthcare. Who is Sequoia Sciences. Sequoia Sciences is a …See details»
Research programme: anticancer therapeutics - Sequoia …
Home. Contact Us. Institution access. Drug Profile. Research programme: anticancer therapeutics - Sequoia Sciences. Alternative Names: Anticancer compounds - Sequoia …See details»
Sequoia Sciences - CB Insights
Overview & Products. Financials. People. Alternatives & Competitors. Executives. 1. Sequoia Sciences Management Team. 1 Team Member. Sequoia Sciences has 1 …See details»
Sequoia Sciences Receives FDA Fast Track Designation for …
LOUIS, July 26, 2017 /PRNewswire/ -- Sequoia Sciences announced it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its novel, …See details»
With $267 Million in Grants Planned for 2024, Sequoia Joins the …
Feb 14, 2024 Sequoia Climate Foundation’s wide-ranging 2021 grants, revealed in tax filings last year, introduced the Irvine-based grantmaker as a giant in climate …See details»
Sequoia Sciences Llc Overview | SignalHire Company Profile
Sequoia Sciences Llc is a private company. The company currently specializes in the Biotechnology area. The Sequoia Sciences Llc annual revenue is estimated at < 1M. To …See details»
Sequoia Sciences Stock Price, Funding, Valuation, Revenue
$49.24M. Investors Count. 3. Funding, Valuation & Revenue. 5 Fundings. Sequoia Sciences has raised $49.24M over 5 rounds. Sequoia Sciences's latest funding round …See details»
Helping or hindering? US scientists debate how to save giant …
Sep 4, 2023 Home. Biology. Ecology. September 4, 2023. Editors' notes. Helping or hindering? US scientists debate how to save giant sequoias. by Huw GRIFFITH. …See details»
Sequoia AT | Life Sciences
In the dynamic world of life sciences, Sequoia leads the way with unparalleled experience in life sciences software development. Our specialization lies in the creation of data …See details»
Named Research Organizations - science.gc.ca
Introduction. The Policy on Sensitive Technology Research and Affiliations of Concern provides that research grant applications submitted by a university or affiliated research …See details»